Pharmafile Logo
T40 2022 Cover
Diversity, Equity and Inclusion
Communiqué 53 Cover Image
- PMLiVE

Tamara Ghanem

- PMLiVE

Sanofi and Sobi’s Altuviiio label updated by FDA with expanded paediatric data in haemophilia A

The therapy’s weekly dosing has a half-life of up to four times longer than current factor VIII therapies

- PMLiVE

Women in pharma

Iona Everson from PMGroup spoke to Ioana Parsons, general manager of Ipsen UK and Ireland, about her career path and her experiences working in pharma

- PMLiVE

Empowering Nurses Through Education

Nurse education is powerful and makes an impact.

Medscape Education Global

- PMLiVE

Johnson & Johnson to expand dermatology portfolio with $850m Proteologix acquisition

The company will gain access to two treatments for atopic dermatitis

- PMLiVE

GSK becomes first founding partner of global initiative tackling antimicrobial resistance

AMR could cause an estimated ten million deaths every year by 2050 unless action is taken

- PMLiVE

Governments continue proposed pandemic agreement progress ahead of World Health Assembly

The meeting focusing on ‘All for Health, Health for All’ takes place on 27 May to 7 June 2024

- PMLiVE

Study reveals new breast cancer genes found in women of African ancestry

More than 240,000 cases of breast cancer are diagnosed in the US every year

- PMLiVE

The PM Society announces Sumira Riaz as Patient Engagement Interest Group co-chair

Riaz has been working as a patient engagement lead at OPEN Health for the last seven years

Enhancing Virtual Training: Role-Playing in Meetings – Impetus InSite Tips #7

Explore the effectiveness of role-playing in virtual meetings with our seventh tip. Learn how assigning roles like "influencer" or "educator" can deepen understanding and enhance communication skills among participants.

Impetus Digital

- PMLiVE

Bristol Myers Squibb’s Breyanzi granted FDA accelerated approval for follicular lymphoma

The disease accounts for up to 30% of all non-Hodgkin lymphoma cases

- PMLiVE

Takeda’s Qdenga becomes second dengue vaccine to receive WHO prequalification

Approximately half of the global population is at risk of mosquito-borne viral disease

- PMLiVE

AstraZeneca’s sipavibart shown to prevent COVID-19 in immunocompromised patients

Immunocompromised individuals account for about 25% of COVID-19 hospitalisations, intensive care unit admissions and deaths

Subscribe to our email news alerts

Latest jobs from #PharmaRole

Latest content

Latest intelligence

Quick links